First and Foremost, great presentation. Point of care testing is growing at faster rate. When it comes supplier of devices and reagents, Transasia is market leader volume wise whereas Roche is market leader value wise.
Package testing has higher margins because less instruments are utilised for achieving desired results. Let's say you have to test for complete blood count and ESR. If done together, one sample will suffice , one syringe. If you decide to do these separately you have to use 2 syringes, 2 collection tube samples and reagents and cost of processing the machine and blood collection. So packages where at one go samples are collected and tested are obviously cheaper providing higher margins. Secondly about rapid tests like detecting heart attack, there is a test called Troponin T which by rapid immunoassay can indicate outcome with few drops of blood. But these kind of tests are rapid but not that sensitive and specific. Chances of false negative and false positive are higher. So they can't replace detailed procedures. Even urine pregnancy tests like preganews are not confirmative, sonography has to be done for accurate detection of pregnancy.
The bundle is higher margin because they have clubbed those tests with routine tests , which are having low turn over. So overall average turnover is increased. Customer is tempted to get 10 tests done when he only needs 3-4.
High doctor commission is the hurdle for this business.however increasing molecular testing and biomarker have definitely give edge over traditional independent labs
Thanks great insight into the industry and fantastic presentation with clear understanding from different areas of the business it would be great to talk in person with you regarding setting up state of the art systems that have a very quick return in the results
Hello, That's a great video congrats! I have just one question if i may, does this market research represent only the diagnostic business in India or Worlwide as well?
'Vidyo narayano hari'....Doctor is equal to God. Respect it. Don't think like it's a profitable business. There is no GST on Healthcare because its a no profit or no loss business. It's a service. Plz understand the motto, then think about the investment.
Plz don't expect centralised database and accessing past reports, max 2% labs have that facility in India. Very important point is that around 30-50% commission these labs should pay back to doctors for sending patients. And these transactions nowhere maintained for income tax calculations. Hence most of the 'patient centric labs' never maintain the history.
This presentation is typically called a presentation without even knowing the truth..ground work is entirely different from this presentation...... Do a proper homework...... Not even mention of at least a single test with its price
First and Foremost, great presentation. Point of care testing is growing at faster rate. When it comes supplier of devices and reagents, Transasia is market leader volume wise whereas Roche is market leader value wise.
In span of one hour ...now we have some knowledge how they work..thanks for the informal
Package testing has higher margins because less instruments are utilised for achieving desired results. Let's say you have to test for complete blood count and ESR. If done together, one sample will suffice , one syringe. If you decide to do these separately you have to use 2 syringes, 2 collection tube samples and reagents and cost of processing the machine and blood collection. So packages where at one go samples are collected and tested are obviously cheaper providing higher margins.
Secondly about rapid tests like detecting heart attack, there is a test called Troponin T which by rapid immunoassay can indicate outcome with few drops of blood. But these kind of tests are rapid but not that sensitive and specific. Chances of false negative and false positive are higher. So they can't replace detailed procedures. Even urine pregnancy tests like preganews are not confirmative, sonography has to be done for accurate detection of pregnancy.
Thanks for this. Interesting to know.
Thanks for the session. It helps in understanding this industry better
The bundle is higher margin because they have clubbed those tests with routine tests , which are having low turn over. So overall average turnover is increased. Customer is tempted to get 10 tests done when he only needs 3-4.
High doctor commission is the hurdle for this business.however increasing molecular testing and biomarker have definitely give edge over traditional independent labs
Insurance in India does pay for the diagnostic tests if in case the diagnosis leads to a treatment that's covered under the policy
Mr Raunak Your voice is great
Great presentation.....but you should have included medlife and other online labs which are gaining market share at fast pace
All these online portals send samples to 3rd party labs only. These are the aggregators only. They don't have processing labs.
Great presentation , Excellent Job PPFAS team
@dear ppfas could you please send the ppt of this presentation .
Thanks great insight into the industry and fantastic presentation with clear understanding from different areas of the business it would be great to talk in person with you regarding setting up state of the art systems that have a very quick return in the results
Request to do new overview video on lab diagnostics business as post COVID industry has changed plus new players have come in..
Very Nice Video ... my PF Down Last Few Month I'm investing without worry ....
Can I use these slides for my lectures?
how can i see such more content related to same topic ?
hI, THANKS! I FEEL that you brought up ESG. well done!
Very well explained. I find it very useful.
Excellent research done!
My first question is do I have to be a doctor or have expertise in medical lab technology to start this business
Not necessary
Can your share your research slides please?
Well explained Thanks
very informative
EXCELLENT WATCHING FROM KENYA
Cameroonian
Sir how to getting machines for testing purposes
Please share the PPT used in this video
Hello,
That's a great video congrats!
I have just one question if i may, does this market research represent only the diagnostic business in India or Worlwide as well?
Nice presentation
What about doctors 50% commission ...why will they refer to you ...???
I didn't know this act occurs in India as well. Its another struggle experienced in the west African market as well
great
'Vidyo narayano hari'....Doctor is equal to God. Respect it. Don't think like it's a profitable business. There is no GST on Healthcare because its a no profit or no loss business. It's a service. Plz understand the motto, then think about the investment.
It's Pathology, not Pathalogy... 😱😱😱😱
cool bngye sir aap to
Plz don't expect centralised database and accessing past reports, max 2% labs have that facility in India. Very important point is that around 30-50% commission these labs should pay back to doctors for sending patients. And these transactions nowhere maintained for income tax calculations. Hence most of the 'patient centric labs' never maintain the history.
Hospital charge deposits and commission which is exuberant...
Doctor/ hospital commission 50%. Ganda hai par dhanda hai yeh..
This presentation is typically called a presentation without even knowing the truth..ground work is entirely different from this presentation...... Do a proper homework...... Not even mention of at least a single test with its price
This is not for you 😂